Healthcare provider profile · identity verified

Raj Vellody, MD

Internal Medicine · MELBOURNE, FL · NPI 1144285818

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	784	218
Levothyroxine Sodium	Levothyroxine Sodium	711	197
Amlodipine Besylate	Amlodipine Besylate	490	144
Alprazolam	Alprazolam	450	83
Lisinopril	Lisinopril	399	116
Losartan Potassium	Losartan Potassium	368	108
Metformin Hcl	Metformin Hcl	305	89
Rosuvastatin Calcium	Rosuvastatin Calcium	291	82
Omeprazole	Omeprazole	281	87
Pantoprazole Sodium	Pantoprazole Sodium	256	83
Metoprolol Succinate	Metoprolol Succinate	255	76
Simvastatin	Simvastatin	211	61
Furosemide	Furosemide	193	76
Methylprednisolone	Methylprednisolone	192	138
Albuterol Sulfate Hfa	Albuterol Sulfate	176	62
Gabapentin	Gabapentin	171	51
Azelastine Hcl	Azelastine Hcl	168	96
Zolpidem Tartrate	Zolpidem Tartrate	165	50
Hydrochlorothiazide	Hydrochlorothiazide	161	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	29
Tamsulosin Hcl	Tamsulosin Hcl	148	50
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	140	22
Atenolol	Atenolol	139	40
Sertraline Hcl	Sertraline Hcl	133	42
Oxycodone Hcl	Oxycodone Hcl	132	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	131	92
Allopurinol	Allopurinol	127	39
Metoprolol Tartrate	Metoprolol Tartrate	124	40
Tizanidine Hcl	Tizanidine Hcl	124	53
Tramadol Hcl	Tramadol Hcl	122	32
Escitalopram Oxalate	Escitalopram Oxalate	121	38
Ezetimibe	Ezetimibe	121	35
Clopidogrel	Clopidogrel Bisulfate	106	30
Doxycycline Hyclate	Doxycycline Hyclate	105	92
Carvedilol	Carvedilol	103	30
Montelukast Sodium	Montelukast Sodium	99	32
Pravastatin Sodium	Pravastatin Sodium	98	28
Eliquis	Apixaban	92	29
Mounjaro	Tirzepatide	92	21
Bupropion Xl	Bupropion Hcl	89	30
Celecoxib	Celecoxib	86	32
Citalopram Hbr	Citalopram Hydrobromide	86	20
Fluticasone Propionate	Fluticasone Propionate	82	32
Lorazepam	Lorazepam	82	22
Duloxetine Hcl	Duloxetine Hcl	81	24
Meloxicam	Meloxicam	76	26
Trazodone Hcl	Trazodone Hcl	73	27
Lovastatin	Lovastatin	72	20
Potassium Chloride	Potassium Chloride	68	23
Synthroid	Levothyroxine Sodium	65	20
Clonazepam	Clonazepam	62	13
Diclofenac Sodium	Diclofenac Sodium	62	20
Glimepiride	Glimepiride	62	23
Ibuprofen	Ibuprofen	58	19
Diazepam	Diazepam	54	21
Metformin Hcl Er	Metformin Hcl	54	18
Mupirocin	Mupirocin	54	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	22
Glipizide Er	Glipizide	50	12
Valsartan	Valsartan	49	16
Famotidine	Famotidine	48	17
Ozempic	Semaglutide	48	13
Jardiance	Empagliflozin	47	suppressed
Meclizine Hcl	Meclizine Hcl	46	14
Januvia	Sitagliptin Phosphate	45	11
Trulicity	Dulaglutide	44	11
Lamotrigine	Lamotrigine	43	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	11
Ropinirole Hcl	Ropinirole Hcl	41	15
Azithromycin	Azithromycin	40	34
Valacyclovir	Valacyclovir Hcl	40	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Xarelto	Rivaroxaban	39	12
Clonidine Hcl	Clonidine Hcl	38	14
Spironolactone	Spironolactone	38	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	24
Enalapril Maleate	Enalapril Maleate	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	13
Finasteride	Finasteride	36	11
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	21
Glipizide	Glipizide	32	12
Naproxen	Naproxen	32	suppressed
Ramipril	Ramipril	32	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Varenicline Tartrate	Varenicline Tartrate	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	12
Baclofen	Baclofen	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Methocarbamol	Methocarbamol	28	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Prednisone	Prednisone	23	15
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Fluconazole	Fluconazole	21	18
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	17
Temazepam	Temazepam	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Estradiol	Estradiol	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Nystatin	Nystatin	17	13
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ondansetron Odt	Ondansetron	16	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Cephalexin	Cephalexin	15	11
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Telmisartan	Telmisartan	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Testosterone	Testosterone	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Aliskiren	Aliskiren Hemifumarate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Toprol Xl	Metoprolol Succinate	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error